Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012-2016.

Pease C, Zwerling A, Mallick R, Patterson M, Demaio P, Finn S, Allen J, Van Dyk D, Alvarez GG.

BMC Infect Dis. 2019 Oct 24;19(1):890. doi: 10.1186/s12879-019-4557-3.

2.

How vision governs the collective behaviour of dense cycling pelotons.

Belden J, Mansoor MM, Hellum A, Rahman SR, Meyer A, Pease C, Pacheco J, Koziol S, Truscott TT.

J R Soc Interface. 2019 Jul 26;16(156):20190197. doi: 10.1098/rsif.2019.0197. Epub 2019 Jul 10.

3.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Hackett KL, Davies K, Tarn J, Bragg R, Hargreaves B, Miyamoto S, McMeekin P, Mitchell S, Bowman S, Price EJ, Pease C, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2019 Apr 24;5(1):e000885. doi: 10.1136/rmdopen-2018-000885. eCollection 2019.

4.

Social determinants of health among residential areas with a high tuberculosis incidence in a remote Inuit community.

Kilabuk E, Momoli F, Mallick R, Van Dyk D, Pease C, Zwerling A, Potvin SE, Alvarez GG.

J Epidemiol Community Health. 2019 May;73(5):401-406. doi: 10.1136/jech-2018-211261. Epub 2019 Feb 6.

PMID:
30728201
5.

Assessment of an ultra-sensitive IFNγ immunoassay prototype for latent tuberculosis diagnosis.

Ben Salah E, Dorgham K, Lesénéchal M, Pease C, Allard L, Dragonetti C, Gorochov G, Guihot A, Sterlin D.

Eur Cytokine Netw. 2018 Nov 1;29(4):136-145. doi: 10.1684/ecn.2018.0417.

PMID:
30714575
6.

Catheter Tract Metastasis in Mesothelioma Patients with Indwelling Pleural Catheters: A Retrospective Cohort Study.

Mitchell MA, Li P, Pease C, Hosseini S, Souza C, Zhang T, Amjadi K.

Respiration. 2019;97(5):428-435. doi: 10.1159/000494500. Epub 2018 Dec 13.

PMID:
30544117
7.

Freshwater chronic ammonia toxicity: A tropical-to-temperate comparison.

Mooney TJ, Pease CJ, Hogan AC, Trenfield M, Kleinhenz LS, Humphrey C, van Dam RA, Harford AJ.

Environ Toxicol Chem. 2019 Jan;38(1):177-189. doi: 10.1002/etc.4313. Epub 2018 Dec 20.

PMID:
30447090
8.

Acute Unilateral Sacroiliitis Mimicking Infection on Magnetic Resonance Imaging with Response to Nonsteroidal Antiinflammatory Drugs: A Distinct Presentation of Spondyloarthritis?

Dubash S, Pease C, Aslam A, Coady D, McGONAGLE D, Marzo-Ortega H.

J Rheumatol. 2018 Dec;45(12):1708-1710. doi: 10.3899/jrheum.171456. Epub 2018 Aug 15. No abstract available.

9.

On chip quadruplex priming amplification for quantitative isothermal diagnostics.

Pease C, Plum GE, Kankia B, Kwiek JJ, Sooryakumar R.

Biomed Microdevices. 2018 Jul 4;20(3):56. doi: 10.1007/s10544-018-0305-5.

PMID:
29974254
10.

Validation of the nickel biotic ligand model for locally relevant species in Australian freshwaters.

Peters A, Merrington G, Schlekat C, De Schamphelaere K, Stauber J, Batley G, Harford A, van Dam R, Pease C, Mooney T, Warne M, Hickey C, Glazebrook P, Chapman J, Smith R, Krassoi R.

Environ Toxicol Chem. 2018 Oct;37(10):2566-2574. doi: 10.1002/etc.4213. Epub 2018 Aug 28.

PMID:
29923627
11.

A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection.

Pease C, Hutton B, Yazdi F, Wolfe D, Hamel C, Barbeau P, Skidmore B, Alvarez GG.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):557-566. doi: 10.1002/pds.4423. Epub 2018 Mar 23.

PMID:
29573031
12.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.

Dumusc A, Ng WF, James K, Griffiths B, Price E, Pease C, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Gupta M, McLaren J, Cooper A, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman S.

Swiss Med Wkly. 2018 Feb 7;148:w14588. doi: 10.4414/smw.2018.14588. eCollection 2018.

13.

Modeling the pH-ammonia toxicity relationship for Hydra viridissima in soft waters with low ionic concentrations.

Mooney TJ, Pease C, Trenfield M, van Dam R, Harford AJ.

Environ Toxicol Chem. 2018 Apr;37(4):1189-1196. doi: 10.1002/etc.4071. Epub 2018 Feb 23.

PMID:
29280172
14.

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

Fisher BA, Everett CC, Rout J, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Carr A, Pease CT, Price EJ, Sutcliffe N, Makdissi J, Tappuni AR, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Richards A, Sharples LD, Bombardieri M, Bowman SJ.

Ann Rheum Dis. 2018 Mar;77(3):412-416. doi: 10.1136/annrheumdis-2017-212268. Epub 2017 Dec 23.

15.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ.

Rheumatology (Oxford). 2017 Dec 1;56(12):2255. doi: 10.1093/rheumatology/kex331. No abstract available.

16.

Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses.

Pease C, Hutton B, Yazdi F, Wolfe D, Hamel C, Quach P, Skidmore B, Moher D, Alvarez GG.

BMC Infect Dis. 2017 Apr 11;17(1):265. doi: 10.1186/s12879-017-2377-x. Review.

17.

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.

Bowman SJ, Everett CC, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Pease CT, Price EJ, Sutcliffe N, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Reynolds C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Giles IP, Sharples LD, Bombardieri M.

Arthritis Rheumatol. 2017 Jul;69(7):1440-1450. doi: 10.1002/art.40093. Epub 2017 Jun 5.

18.

A shorter treatment regimen for latent tuberculosis infection holds promise for at-risk Canadians.

Pease C, Amaratunga KR, Alvarez GG.

Can Commun Dis Rep. 2017 Mar 2;43(3-4):67-71. eCollection 2017 Mar 2.

19.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O'Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. Epub 2016 Dec 29.

20.

Physical activity but not sedentary activity is reduced in primary Sjögren's syndrome.

Ng WF, Miller A, Bowman SJ, Price EJ, Kitas GD, Pease C, Emery P, Lanyon P, Hunter J, Gupta M, Giles I, Isenberg D, McLaren J, Regan M, Cooper A, Young-Min SA, McHugh N, Vadivelu S, Moots RJ, Coady D, MacKay K, Dasgupta B, Sutcliffe N, Bombardieri M, Pitzalis C, Griffiths B, Mitchell S, Miyamoto ST, Trenell M; UK Primary Sjögren’s Syndrome Registry.

Rheumatol Int. 2017 Apr;37(4):623-631. doi: 10.1007/s00296-016-3637-6. Epub 2016 Dec 24.

21.

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy.

Bezzina OM, Gallagher P, Mitchell S, Bowman SJ, Griffiths B, Hindmarsh V, Hargreaves B, Price EJ, Pease CT, Emery P, Lanyon P, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper AM, Regan M, Giles IP, Isenberg DA, Saravanan V, Coady D, Dasgupta B, McHugh NJ, Young-Min SA, Moots RJ, Gendi N, Akil M, MacKay K, Ng WF, Robinson LJ; UK Primary Sjögren's Syndrome Registry.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1714-1723. doi: 10.1002/acr.23165. Epub 2017 Oct 9.

22.

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.

Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W, Masters S, McDonald B, McNally E, Pease C, Piper J, Salmon J, Wailoo A, Wolfe K, Hutchings A.

Health Technol Assess. 2016 Nov;20(90):1-238.

23.

Increasing uranium exposure durations to the aquatic snail Amerianna cumingi does not result in lower toxicity estimates.

Mooney TJ, Harford AJ, Trenfield MA, Pease CJ, Hogan AC, van Dam RA.

Environ Toxicol Chem. 2016 Nov;35(11):2851-2858. doi: 10.1002/etc.3467. Epub 2016 Jul 7.

PMID:
27115938
24.

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines.

Howard Tripp N, Tarn J, Natasari A, Gillespie C, Mitchell S, Hackett KL, Bowman SJ, Price E, Pease CT, Emery P, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg DA, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2016 Jul 19;2(2):e000282. doi: 10.1136/rmdopen-2016-000282. eCollection 2016.

25.

Rheumatoid arthritis.

Harnden K, Pease C, Jackson A.

BMJ. 2016 Mar 23;352:i387. doi: 10.1136/bmj.i387. No abstract available.

PMID:
27009280
26.

Review of the Evidence from Epidemiology, Toxicology, and Lung Bioavailability on the Carcinogenicity of Inhaled Iron Oxide Particulates.

Pease C, Rücker T, Birk T.

Chem Res Toxicol. 2016 Mar 21;29(3):237-54. doi: 10.1021/acs.chemrestox.5b00448. Epub 2016 Feb 24. Review.

PMID:
26863929
27.
28.

Systematic review in chemical risk assessment - A chemical industry perspective.

Pease CK, Gentry RP.

Environ Int. 2016 Jul-Aug;92-93:574-7. doi: 10.1016/j.envint.2015.12.007. Epub 2015 Dec 22.

PMID:
26705743
29.

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.

James K, Al-Ali S, Tarn J, Cockell SJ, Gillespie CS, Hindmarsh V, Locke J, Mitchell S, Lendrem D, Bowman S, Price E, Pease CT, Emery P, Lanyon P, Hunter JA, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B; UK Primary Sjögren’s Syndrome registry, Wipat A, Newton J, Jones DE, Isaacs J, Hallinan J, Ng WF.

PLoS One. 2015 Dec 22;10(12):e0143970. doi: 10.1371/journal.pone.0143970. eCollection 2015.

30.

Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendations.

Whaley P, Halsall C, Ågerstrand M, Aiassa E, Benford D, Bilotta G, Coggon D, Collins C, Dempsey C, Duarte-Davidson R, FitzGerald R, Galay-Burgos M, Gee D, Hoffmann S, Lam J, Lasserson T, Levy L, Lipworth S, Ross SM, Martin O, Meads C, Meyer-Baron M, Miller J, Pease C, Rooney A, Sapiets A, Stewart G, Taylor D.

Environ Int. 2016 Jul-Aug;92-93:556-64. doi: 10.1016/j.envint.2015.11.002. Epub 2015 Dec 11.

31.

Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.

Helliwell T, Brouwer E, Pease CT, Hughes R, Hill CL, Neill LM, Halls S, Simon LS, Mallen CD, Boers M, Kirwan JR, Mackie SL.

J Rheumatol. 2016 Jan;43(1):182-6. doi: 10.3899/jrheum.141179. Epub 2015 Nov 15. Review.

32.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ; UK Primary Sjögren’s Syndrome Registry.

Rheumatology (Oxford). 2016 Mar;55(3):544-52. doi: 10.1093/rheumatology/kev373. Epub 2015 Oct 27. Erratum in: Rheumatology (Oxford). 2017 Dec 1;56(12 ):2255.

33.

Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids.

Mackie SL, Pease CT, Fukuba E, Harris E, Emery P, Hodgson R, Freeston J, McGonagle D.

Ann Rheum Dis. 2015 Dec;74(12):2188-92. doi: 10.1136/annrheumdis-2015-207395. Epub 2015 Sep 16.

34.

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B; European League Against Rheumatism; American College of Rheumatology.

Ann Rheum Dis. 2015 Oct;74(10):1799-807. doi: 10.1136/annrheumdis-2015-207492.

35.

2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B; European League Against Rheumatism; American College of Rheumatology.

Arthritis Rheumatol. 2015 Oct;67(10):2569-80. doi: 10.1002/art.39333.

36.

Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy.

Saint-Pierre MD, Pease C, Mithoowani H, Zhang T, Nicholas GA, Laurie SA, Wheatley-Price P.

Lung Cancer Int. 2015;2015:590148. doi: 10.1155/2015/590148. Epub 2015 Mar 2.

37.

Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Mackie SL, Taylor JC, Haroon-Rashid L, Martin S, Dasgupta B, Gough A, Green M, Hordon L, Jarrett S, Pease CT, Barrett JH, Watts R, Morgan AW; UK GCA Consortium; UKRAG Consortium.

Arthritis Res Ther. 2015 Jul 30;17:195. doi: 10.1186/s13075-015-0692-4.

38.

"An impediment to living life": why and how should we measure stiffness in polymyalgia rheumatica?

Mackie SL, Hughes R, Walsh M, Day J, Newton M, Pease C, Kirwan J, Morris M.

PLoS One. 2015 May 8;10(5):e0126758. doi: 10.1371/journal.pone.0126758. eCollection 2015.

39.

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Carmona FD, Mackie SL, Martín JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, Morado IC, Narváez J, Miranda-Filloy JA; Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schönau V, Franke A, Palm Ø, Molberg Ø, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, González-Gay MA, Morgan AW, Martín J.

Am J Hum Genet. 2015 Apr 2;96(4):565-80. doi: 10.1016/j.ajhg.2015.02.009. Epub 2015 Mar 26.

40.

Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.

Vital EM, Wittmann M, Edward S, Md Yusof MY, MacIver H, Pease CT, Goodfield M, Emery P.

Arthritis Rheumatol. 2015 Jun;67(6):1586-91. doi: 10.1002/art.39085.

41.

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

Lendrem D, Mitchell S, McMeekin P, Gompels L, Hackett K, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Ng WF; UK primary Sjögren’s Syndrome Registry.

Rheumatology (Oxford). 2015 Apr;54(4):655-9. doi: 10.1093/rheumatology/keu361. Epub 2014 Sep 19.

42.

Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results.

Juarez M, Toms TE, de Pablo P, Mitchell S, Bowman S, Nightingale P, Price EJ, Griffiths B, Hunter J, Gupta M, Bombardieri M, Sutdliffe N, Pitzalis C, Pease C, Andrews J, Emery P, Regan M, Giles I, Isenberg D, Moots R, Collins KS, Ng WF, Kitas GD; UK Primary Sjögren’s Syndrome Registry.

Arthritis Care Res (Hoboken). 2014 May;66(5):757-64.

43.

A milestone-based approach to breast imaging instruction for residents.

Harvey JA, Nicholson BT, Rochman CM, Peppard HR, Pease CS, DeMartini NA.

J Am Coll Radiol. 2014 Jun;11(6):600-5. doi: 10.1016/j.jacr.2014.01.007. Epub 2014 Apr 26.

PMID:
24780508
44.

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR.

Mackie SL, Arat S, da Silva J, Duarte C, Halliday S, Hughes R, Morris M, Pease CT, Sherman JW, Simon LS, Walsh M, Westhovens R, Zakout S, Kirwan JR.

J Rheumatol. 2014 Apr;41(4):819-23. doi: 10.3899/jrheum.131254. Epub 2014 Feb 1. Review.

PMID:
24488422
45.

The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome.

Brown S, Navarro Coy N, Pitzalis C, Emery P, Pavitt S, Gray J, Hulme C, Hall F, Busch R, Smith P, Dawson L, Bombardieri M, Wan-Fai N, Pease C, Price E, Sutcliffe N, Woods C, Ruddock S, Everett C, Reynolds C, Skinner E, Poveda-Gallego A, Rout J, Macleod I, Rauz S, Bowman S; TRACTISS trial team.

BMC Musculoskelet Disord. 2014 Jan 17;15:21. doi: 10.1186/1471-2474-15-21.

46.

Health-related utility values of patients with primary Sjögren's syndrome and its predictors.

Lendrem D, Mitchell S, McMeekin P, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Ng WF; UK primary Sjögren's Syndrome Registry.

Ann Rheum Dis. 2014 Jul;73(7):1362-8. doi: 10.1136/annrheumdis-2012-202863. Epub 2013 Jun 12.

PMID:
23761688
47.

Do rheumatologists think about sex?

Pease E, Pease B, Pease C.

Reumatol Clin. 2013 Jul-Aug;9(4):255. doi: 10.1016/j.reuma.2013.03.001. Epub 2013 Apr 19. No abstract available.

48.

Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips.

Mackie SL, Pease CT.

Postgrad Med J. 2013 May;89(1051):284-92. doi: 10.1136/postgradmedj-2012-131400. Epub 2013 Jan 25. Review.

PMID:
23355687
49.

Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis.

Mackie SL, Hensor EM, Morgan AW, Pease CT.

Ann Rheum Dis. 2014 Jan;73(1):143-8. doi: 10.1136/annrheumdis-2012-202145. Epub 2012 Dec 22. Review.

PMID:
23264356
50.

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.

Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF; UK primary Sjögren's syndrome registry.

Ann Rheum Dis. 2012 Dec;71(12):1973-9. doi: 10.1136/annrheumdis-2011-201009. Epub 2012 May 5.

Supplemental Content

Support Center